Pine Bridge Investments, L.P. Vanda Pharmaceuticals Inc. Transaction History

Pine Bridge Investments, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$7.5 - $16.8 $298,980 - $669,715	-39,864 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$12.38 - $17.47 $339,521 - $479,114	-27,425 Reduced 40.76%	39,864 $654,000
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $152,749 - $196,569	12,449 Added 22.7%	67,289 $894,000
Q2 2019 Aug 13, 2019	BUY	$13.37 - $18.85 $538,904 - $759,786	40,307 Added 277.35%	54,840 $772,000
Q1 2019 May 14, 2019	SELL	$17.59 - $31.05 $37,009 - $65,329	-2,104 Reduced 12.65%	14,533 $267,000
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $315,603 - $523,566	16,637 New	16,637 $435,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.